Find Clinical Trial
The efficacy and safety of trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention ATPCI study. An international, multicentre, randomised, double-blind, placebo-controlled study in patients treated for 2 to 4 years.
← Back
| Study Phase |
Phase 3 |
| Therapeutic Area |
Cardiovascular Diseases |
| Indication | Coronary Artery Disease |
| Sponsor | Institut de Recherches Internationales Servier (I.R.I.S) |
| Active substance/ Medical device |
TRIMETAZIDINE, |
| Active Substance Code | S006790 |
| Protocol Code | CL3-06790-010 |
| EudraCT Code | 2010-022134-89 |
Documents and links
| Lay summary | |
| Results summary | READ MORE  |
| Scientific publication | READ MORE |
Servier Glossary of Terms
To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.
© 2024 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility
